After eight weeks of therapy, fasting plasma glucose and 2-hour postprandial plasma glucose levels in Group R were statistically significantly lower than in Group C.
From these, adding RE therapy to the standard-of-care was inferred to be effective in improving glucose metabolism in patients with metabolic syndrome.
Change in HbA1c – Metabolic Syndrome Clinical Study
Overview (study design, subjects background, etc.) – metabolic syndrome clinical study Therapeutic intervention for Group C: standard-of-careTherapeutic inte…